1-((2R,3R)-3-(4-(4-CYANOPHENYL)-2-THIAZOLYL)-2-(2,5-DIFLUOROPHENYL)-2-HYDROXYBUTYL)-4-(1-((((3-(HYDROXYMETHYL)-2-PYRIDINYL)METHYLAMINO)CARBONYL)OXY)ETHYL)-4H-1,2,4-TRIAZOLIUM
UNII J26UQM9LF6
Substance Identification & Data
This profile provides standardized clinical and technical data for 1-((2r,3r)-3-(4-(4-cyanophenyl)-2-thiazolyl)-2-(2,5-difluorophenyl)-2-hydroxybutyl)-4-(1-((((3-(hydroxymethyl)-2-pyridinyl)methylamino)carbonyl)oxy)ethyl)-4h-1,2,4-triazolium, uniquely identified by the FDA Unique Ingredient Identifier (UNII) J26UQM9LF6.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2761502-58-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C32H30F2N7O4S MJWSCYYSSOVPSI-PKOUYPBPSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 1-((2r,3r)-3-(4-(4-cyanophenyl)-2-thiazolyl)-2-(2,5-difluorophenyl)-2-hydroxybutyl)-4-(1-((((3-(hydroxymethyl)-2-pyridinyl)methylamino)carbonyl)oxy)ethyl)-4h-1,2,4-triazolium. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.